Citation: Wg. North et al., EXPRESSION OF ALL KNOWN VASOPRESSIN RECEPTOR SUBTYPES BY SMALL-CELL TUMORS IMPLIES A MULTIFACETED ROLE FOR THIS NEUROPEPTIDE, Cancer research, 58(9), 1998, pp. 1866-1871
Authors:
NORTH WG
FAY MJ
DU JL
CLEARY M
GALLAGHER JD
MCCANN FV
Citation: Wg. North et al., PRESENCE OF FUNCTIONAL NMDA RECEPTORS IN A HUMAN NEUROBLASTOMA CELL-LINE, Molecular and chemical neuropathology, 30(1-2), 1997, pp. 77-94
Citation: Wg. North et al., FUNCTIONAL VASOPRESSIN V-1 TYPE RECEPTORS ARE PRESENT IN VARIANT AS WELL AS CLASSICAL FORMS OF SMALL-CELL CARCINOMA, Peptides, 18(7), 1997, pp. 985-993
Citation: Ka. Longo et al., EVIDENCE FOR THE EXPRESSION OF A NOVEL VASOPRESSIN-ACTIVATED CALCIUM MOBILIZING RECEPTOR (VACM-1) IN HUMAN BREAST-CANCER AND LUNG-CANCER, Molecular biology of the cell, 7, 1996, pp. 3761-3761
Citation: As. Friedmann et al., FACTORS REGULATING THE PRODUCTION OF VASOPRESSIN-ASSOCIATED HUMAN NEUROPHYSIN BY SMALL-CELL CARCINOMA OF THE LUNG - EVALUATION BY COMPUTER-ENHANCED QUANTITATIVE IMMUNOCYTOCHEMISTRY, Neuropeptides, 28(3), 1995, pp. 183-189
Citation: Mj. Fay et Td. Allston, CHARACTERIZATION OF VAPOR-DEPOSITED ALUMINUM COATINGS ON ORIENTED POLYPROPYLENE FILMS, Tappi journal, 77(4), 1994, pp. 125-129
Citation: Mj. Fay et al., EFFECT OF ALDONIC ACIDS ON THE UPTAKE OF ASCORBIC-ACID BY 3T3 MOUSE FIBROBLASTS AND HUMAN T-LYMPHOMA CELLS, General pharmacology, 25(7), 1994, pp. 1465-1469
Citation: Mj. Fay et al., VASOPRESSIN AND VASOPRESSIN-RECEPTOR IMMUNOREACTIVITY IN SMALL-CELL LUNG-CARCINOMA (SCCL) CELL-LINES - DISRUPTION IN THE ACTIVATION CASCADEOF V-1A-RECEPTORS IN VARIANT SCCL, Cancer letters, 82(2), 1994, pp. 167-174